Akorn (AKRX) Announces Launch of Ibuprofen Oral Suspension

November 29, 2016 7:34 AM EST
Get Alerts AKRX Hot Sheet
Trade AKRX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Akorn, Inc. (Nasdaq: AKRX) announced that it has launched the prescription version of Ibuprofen 100mg/5mL oral suspension in 118mL and 473mL bottles as well as 5mL unit dose cups.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News

Add Your Comment